• Full-Dose Anticoagulation Reduces Need for Life Support in COVID-19

    1 month ago - By Medscape

    The benefit, along with a trend to lower mortality, was reported in the subgroup of moderately ill patients hospitalized with COVID-19 taking part in three linked trials.
    Medscape Medical News
    Read more ...

     

  • Full-Dose Clot Prophylaxis Improves Outcomes in Moderate COVID-19

    Full-Dose Clot Prophylaxis Improves Outcomes in Moderate COVID-19

    1 month ago - By MedPageToday

    Therapeutic anticoagulation for thromboembolic prophylaxis improved outcomes and possibly survival in a hospitalized but not critically ill COVID-19 population, according to topline results of three large platform trials released...
    Read more ...